Herbalife Ltd (HLF)

HLF (NYSE:Consumer Non-Durables)
pos +0.00
Today's Range: 0.00 - 0.00 | HLF Avg Daily Volume: 1,997,600
Last Update: 07/28/14 - 4:01 PM EDT
Volume: 0
YTD Performance: -14.26%
Open: $0.00
Previous Close: $67.48
52 Week Range: $49.35 - $83.51
Oustanding Shares: 98,107,055
Market Cap: 6,480,952,053
6-Month Chart
TheStreet Ratings Grade for HLF
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.40 1.40 1.40 1.40
Latest Dividend: 0.30
Latest Dividend Yield: 1.84%
Dividend Ex-Date: 02/28/14
Price Earnings Ratio: 14.52
Price Earnings Comparisons:
HLF Sector Avg. S&P 500
14.52 14.50 28.94
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.66% 15.45% 19.56%
Revenue 18.50 0.76 0.21
Net Income 10.50 0.82 0.22
EPS 21.30 1.11 0.28
Earnings for HLF:
Revenue 4.83B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.63 $1.65 $6.33 $7.35
Number of Analysts 3 3 4 4
High Estimate $1.65 $1.67 $6.40 $7.75
Low Estimate $1.60 $1.62 $6.28 $7.09
Prior Year $1.41 $1.28 $5.37 $6.33
Growth Rate (Year over Year) 15.37% 28.91% 17.88% 16.15%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

This Morning's Market Setup Real Money Pro($)

Where it began.
Earnings beats are plentiful, but guidance is less than stellar.
Do not trade on headlines. Do not trade on releases.
It's a good time to do some premium selling.

Icahn Busts a Move Real Money Pro($)

Break In!
The deck seems stacked against this pharmaceutical powerhouse.
And I did it my way.
It's one confusing day, and investors don't like uncertainty.
Ackman's mission to destroy the company could extend to directors' liability.

Columnist Conversations

I am still watching MON for a possible reversal against the time/price parameters. So far we are not seeing a...
Market stages nice comeback from early losses to end basically flat. Gilead Sciences (GILD)has a nice day post...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Going to $47 without Otis...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.